GSDMB and breast carcinoma: Knockout GSDMB, or intracellular-delivered anti-GSDMB through nanocapsules could neutralize the effects of GSDMB, reduce the aggressiveness of HER2 breast cancer, and enhance the sensitivity to trastuzumab (80).